Publications

TitleHIV treatment produces economic returns through increased work and education, and warrants continued US support
AuthorsHarsha Thirumurthy, Omar Galárraga, Bruce Larson, & Sydney Rosen
PublicationHealth Affairs. 2012 Jul; 31(7):1470-1477.
Abstract

Abstract:

Federal expenditures are under scrutiny in the United States, and the merits of continuing and expanding the President’s Emergency Plan for AIDS Relief (PEPFAR) to support access to antiretroviral therapy have become a topic of debate. A growing body of research on the economic benefits of treatment with antiretroviral therapy has important implications for these discussions. For example, research conducted since the inception of PEPFAR shows that HIV-infected adults who receive antiretroviral therapy often begin or resume productive work, and that children living in households with infected adults who are on treatment are more likely to attend school than those in households with untreated adults. These benefits should be considered when weighing the overall benefits of providing antiretroviral therapy against its costs, particularly in the context of discussions about the future of PEPFAR. A modest case can also be made in favor of having private companies in HIV-affected countries provide antiretroviral therapy to their employees and dependents, thus sharing some of the burden of funding HIV treatment.
URLhttp://content.healthaffairs.org/content/31/7/1470.full
Related ProjectsEconomic Outcomes of HIV/AIDS Treatment in South Africa